Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Diclofenac Epolamine Topical Patch Efficacious and Safe in Elderly Patients With Acute Periarthritis: Presented at AGS - (DGDispatch)
    Novel Urate-Lowering Agent, Febuxostat, Shows Better Results in Older Adults With Gout Compared With Allopurinol: Presented at AGS - (DGDispatch)
    Febuxostat Approved in Europe for the Treatment of Chronic Hyperuricaemia in Patients With Gout - (DGNews)
    Tocilizumab Approved in Japan for the Treatment of Rheumatoid Arthritis - (DGNews)
    FDA Approves Abatacept for the Treatment of Polyarticular Juvenile Idiopathic Arthritis - (DGNews)

    News archive

     Recent webcasts/CME - Arthritis Other
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
    • Inflammatory Arthritis -The Antisynthetase Syndrome
      Inflammatory Arthritis - Gout

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Bilateral Sternoclavicular Joint Septic Arthritis Secondary to Indwelling Central Venous Catheter: A Case Report
        Bowel Associated Dermatosis - Arthritis Syndrome: A Case Report
        Streptobacillus Moniliformis Septic Arthritis: A Clinical Entity Distinct from Rat-Bite Fever?
        Reactive Arthritis of the Temporomandibular Joints and Cervical Spine in a Child
        Reactive Arthritis Developing after Pneumococcal Conjunctivitis: A Case Report

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Juvenile Arthritis Classification Criteria Compared In Nordic Study

        A DGReview of :"Construct Validity of ILAR and EULAR Criteria in Juvenile Idiopathic Arthritis: A Population Based Incidence Study from the Nordic Countries"
        Journal of Rheumatology

        12/14/2001
        By Anne MacLennan


        Comparison of the proposed new and older classification criteria for juvenile idiopathic arthritis is complicated by the differing operational definitions they use of the subvariables.

        Using the new ILAR rather than EULAR criteria, the number of cases with juvenile arthritis increases by 10 percent, considering the first half-year after onset.

        However, validity of the ILAR criteria is low; these criteria frequently exclude patients from subgroup classification, and the possibility of having more than one diagnosis is not negligible. Furthermore, specified exclusion criteria for some of the subgroups are difficult to fulfill in clinical work, and the variables involved are questionable in terms of their consistency.

        Construct validity of the two sets of criteria refers to how closely the two instruments are related and how each operates in classifying subgroups/categories.

        The proposed new criteria (ILAR) are more descriptive than those formerly used [American College of Rheumatology (ACR), European League Against Rheumatism (EULAR)] but require validation against classifications already in use. This research group validated the ILAR in relation to the EULAR criteria and analysed their feasibility.

        In the study, 20 doctors in five Nordic countries collected data from the incidence cases within their catchment areas over an 18-month period beginning July 1, 1997. Clinical and serological data from the first year of disease were collected. A total of 322 patients were included.

        Classification by the ILAR criteria was possible in 321 patients; 290 patients had a disease duration of three months or less and were classified according to the EULAR criteria. One child could only be classified according to the EULAR criteria.

        Thus, 31 of 322 children (9.6 percent) were classified according to the ILAR criteria only. Forty-eight of 321 patients (15 percent) did not fit any category, and 6 percent (20 of 321) fulfilled criteria for two categories.

        In the ILAR classification, five of seven categories/subgroups have two to five specified exclusion criteria that highly discriminate the definition of each patient.

        In this study, the exclusion criteria were fulfilled to only a small extent.

        Study author is Lillemor Berntson and colleagues for the Nordic Study Group following a population-based incidence study in the Nordic countries of the construct validity of the EULAR and ILAR criteria in juvenile idiopathic arthritis.
        J Rheumatol 2001;28:2737-43. "Construct Validity of ILAR and EULAR Criteria in Juvenile Idiopathic Arthritis: A Population Based Incidence Study from the Nordic Countries"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send